TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33377903

Group type: EXPERIMENTAL
Intervention: hrHPV testing
Number of subjects: 60732

Group type: COMPARATOR
Intervention: Cytology triage for hrHPV-positive rural women
Number of subjects: 60732

Group type: COMPARATOR
Intervention: Genotyping for hrHPV with cytology triage
Number of subjects: 60732
Study: 32035420

Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study: 36126290

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment (zero-intensity laser)
Number of subjects: 32
Study: 35757424

Group type: COMPARATOR
Intervention: Low-Intensity Interval Resistance Training (LIIRT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Moderate-Intensity Interval Resistance Training (MIIRT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: High-Intensity Interval Resistance Training (HIIRT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 44
Study: 32192482

Group type: EXPERIMENTAL
Intervention: Individualized 3D-printed navigation templates
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traditional surgery
Number of subjects: 35
Study: 35341915

Group type: EXPERIMENTAL
Intervention: Complement and coagulation proteins
Number of subjects: 158

Group type: COMPARATOR
Intervention: Cytokines, proteomic or fatty acid data
Number of subjects: 158
Study: 32659116

Group type: EXPERIMENTAL
Intervention: HIIT+RT (cycling 4 bouts of 4-min at 90% of HRmax followed by 3 sets of 12 repetitions of 3 lower limb free-weight exercises)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: HIIT+HIIT (cycling 5 bouts of 4 min at 90% of HRmax)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 87
Study: 35247245

Group type: EXPERIMENTAL
Intervention: Small incision open reduction and cannulated screw internal fixation
Number of subjects: 72

Group type: COMPARATOR
Intervention: Arthroscopic high strength non-absorbable suture
Number of subjects: 72
Study: 32888230

Group type: EXPERIMENTAL
Intervention: Varenicline (n = 407)
Number of subjects: 1051

Group type: EXPERIMENTAL
Intervention: Combination nicotine replacement therapy (C‐NRT) (n = 421)
Number of subjects: 1051

Group type: COMPARATOR
Intervention: Nicotine patch monotherapy (control) (n = 230)
Number of subjects: 1051
Study: 35945001

Group type: EXPERIMENTAL
Intervention: Atrial Fibrillation (AF)
Number of subjects: 2844
Study: 33938053

Group type: EXPERIMENTAL
Intervention: Bedrest (BR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 15
Study: 35275196

Group type: EXPERIMENTAL
Intervention: AZD4017 (400 mg oral, twice daily for 90 days)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (matched placebo for 90 days)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: AZD4017
Number of subjects: 55
Study: 35644168

Group type: EXPERIMENTAL
Intervention: dNS1-RBD vaccine (intranasal spray)
Number of subjects: 1084
Study: 34030885

Group type: EXPERIMENTAL
Intervention: Adjuvant uracil‐tegafur and leucovorin
Number of subjects: 180

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Curative repeated resection
Number of subjects: 180
Study: 33104433

Group type: COMPARATOR
Intervention: Standard care (bordered polyurethane dressing plus nonsterile tape over the extension tubing)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Standard care plus two sterile tape strips over the PIVC hub
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Standard care plus two sterile tape strips over the PIVC hub plus a tubular bandage
Number of subjects: 105
Study: 36027994

Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Guideline Dietary Amounts (GDA)
Number of subjects: 1951

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL)
Number of subjects: 1951

Group type: COMPARATOR
Intervention: Control condition (no label)
Number of subjects: 1951
Study: 32508218

Group type: EXPERIMENTAL
Intervention: Algebraic equation solving intervention (Mystery Math), 30 min per session, 3 sessions per week for 5 weeks (15 sessions)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 48
Study: 32002583

Group type: EXPERIMENTAL
Intervention: 20 mg propranolol orally every 12 hours up to 10 days or until discharge (BB+)
Number of subjects: 219

Group type: COMPARATOR
Intervention: No propranolol (BB-)
Number of subjects: 219
Study: 34474598

Group type: EXPERIMENTAL
Intervention: Computerized executive function training program under the guidance of a coach
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 70
Study: 34459396

Group type: EXPERIMENTAL
Intervention: Low-value care (LvC)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: High-value care (HvC)
Number of subjects: 516
Study: 36339271

Group type: EXPERIMENTAL
Intervention: Pimavanserin
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 35226566

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Moderate continuous training (MCT)
Number of subjects: 31
Study: 32476080

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 2075
Study: 33966952

Group type: EXPERIMENTAL
Intervention: DARTNA (Drum-Assisted Recovery Therapy for Native Americans)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual care plus (control group)
Number of subjects: 63
Study: 32869931

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF, 0.1%) cream with linoleic acid-ceramide (LA-Cer) moisturizer
Number of subjects: 178

Group type: COMPARATOR
Intervention: Mometasone furoate (MF, 0.1%) cream
Number of subjects: 178
Study: 36367488

Group type: COMPARATOR
Intervention: Aerobic training
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Low-load resistance training and aerobic training
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: High-load resistance training and aerobic training
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Very sedentary patients
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Sedentary patients
Number of subjects: 79
Study: 33559168

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shock wave therapy (Li-ESWT) plus pelvic floor muscle training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Pelvic floor muscle exercise and sham therapy by shock wave
Number of subjects: 42
Study: 32236752

Group type: EXPERIMENTAL
Intervention: Caloric restriction with post-exercise carbohydrate (CRC)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Caloric restriction with post-exercise protein (CRP)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Energy balance control (CON)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CRC)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CRP)
Number of subjects: 3
Study: 35858717

Group type: EXPERIMENTAL
Intervention: Adductor canal block alone (ACB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adductor canal block with low-concentration sciatic nerve block (ACB + LC SNB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adductor canal block with high-concentration sciatic nerve block (ACB + HC SNB)
Number of subjects: 0
Study: 34830677

Group type: EXPERIMENTAL
Intervention: Individual reminiscence therapy (RT) sessions, twice weekly for 13 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular activities administered as part of their program (Control)
Number of subjects: 0
Study: 35996179

Group type: EXPERIMENTAL
Intervention: 4 or 6 mg NRT chewing gum for 8 weeks
Number of subjects: 350000000

Group type: EXPERIMENTAL
Intervention: BISCA: face-to-face behavioural support for ST cessation
Number of subjects: 350000000

Group type: EXPERIMENTAL
Intervention: Combination of interventions A and B
Number of subjects: 350000000

Group type: COMPARATOR
Intervention: Usual care (Very Brief Advice - VBA)
Number of subjects: 350000000
Study: 32671561

Group type: EXPERIMENTAL
Intervention: Field margin vegetation assessment using remote sensing and geo-informatics techniques
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Ecological knowledge of local farmers regarding FMV
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Comparison of species dominance in rural vs urban zones
Number of subjects: 355
Study: 36279410

Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 58

Group type: COMPARATOR
Intervention: Neostigmine
Number of subjects: 58
Study: 33355478

Group type: EXPERIMENTAL
Intervention: Adjunctive mangosteen pericarp (1,000 mg/day)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 32414832

Group type: EXPERIMENTAL
Intervention: Exercise training programme consisting of motor control exercise and segmental exercises; specific dosage and duration not provided.
Number of subjects: 0
Study: 35396879

Group type: EXPERIMENTAL
Intervention: Accelerated resolution therapy (ART)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 29
Study: 33653932

Group type: EXPERIMENTAL
Intervention: SRI app
Number of subjects: 60

Group type: COMPARATOR
Intervention: Classic paper SRI
Number of subjects: 60
Study: 32567948

Group type: EXPERIMENTAL
Intervention: Audiovisual distraction using video eyeglasses
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional behaviour management techniques
Number of subjects: 48
Study: 36325897

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg or 150 mg every 2 weeks as an adjunct to background treatment
Number of subjects: 18
Study: 32071052

Group type: EXPERIMENTAL
Intervention: Nitazoxanide (NTZ) 1 g orally twice daily for 14 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 30
Study: 33848255

Group type: EXPERIMENTAL
Intervention: Spelling Errors and Shouting Capitalization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no spelling errors or shouting capitalization)
Number of subjects: 0
Study: 32336479

Group type: EXPERIMENTAL
Intervention: Oral paracetamol
Number of subjects: 161

Group type: COMPARATOR
Intervention: Oral ibuprofen
Number of subjects: 161
Study: 35085510

Group type: EXPERIMENTAL
Intervention: Baloxavir plus NAIs
Number of subjects: 366

Group type: COMPARATOR
Intervention: Placebo plus NAIs (Control)
Number of subjects: 366
Study: 33909726

Group type: EXPERIMENTAL
Intervention: Resilient stud (Locator)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Stress‐free implant bar (SFI‐Bar)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 35484309

Group type: EXPERIMENTAL
Intervention: Nicotine pouch (NP)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Lozenge
Number of subjects: 34

Group type: COMPARATOR
Intervention: Gum
Number of subjects: 34
Study: 34529962

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5×10^10 viral particles) followed by MVA-BN-Filo (1×10^8 infectious units) on day 57
Number of subjects: 576

Group type: COMPARATOR
Intervention: MenACWY (first dose) followed by placebo (second dose) on day 57
Number of subjects: 576

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen
Number of subjects: 576
Study: 35640923

Group type: EXPERIMENTAL
Intervention: Combined epicardial and endocardial approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional endocardial approach
Number of subjects: 100
Study: 32621543

Group type: EXPERIMENTAL
Intervention: MHAA4549A 3600 mg
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: MHAA4549A 8400 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 158
Study: 616766147

Group type: EXPERIMENTAL
Intervention: AMF+NFB combinations
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control treatments (no AMF or NFB)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Co-inoculation of AMF and NFB
Number of subjects: 6
Study: 36283845

Group type: EXPERIMENTAL
Intervention: Subcutaneous analgesic system (SAS)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 36
Study: 36471413

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 35342036

Group type: EXPERIMENTAL
Intervention: Positive Psychology Intervention (PPI)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 84
Study: 33227280

Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test (FIT) screening every second year
Number of subjects: 139291

Group type: COMPARATOR
Intervention: Sigmoidoscopy
Number of subjects: 139291

Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test (FIT) screening
Number of subjects: 139291
Study: 33549489

Group type: EXPERIMENTAL
Intervention: APC Plus adhesive coated appliance system with moisture insensitive primer (MIP) under wet conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: APC Plus adhesive coated appliance system with moisture insensitive primer (MIP) under dry conditions
Number of subjects: 24

Group type: COMPARATOR
Intervention: APC Plus adhesive coated appliance system with moisture insensitive primer (MIP) under wet and dry conditions
Number of subjects: 24
Study: 33068631

Group type: EXPERIMENTAL
Intervention: Active TMS
Number of subjects: 22

Group type: COMPARATOR
Intervention: SHAM TMS
Number of subjects: 22
Study: 35343999

Group type: EXPERIMENTAL
Intervention: Educational intervention (brochure and questionnaire on attitudes toward deprescribing)
Number of subjects: 3012

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 3012
Study: 33587893

Group type: EXPERIMENTAL
Intervention: Complete mesocolic excision (CME)
Number of subjects: 995

Group type: COMPARATOR
Intervention: D2 dissection
Number of subjects: 995
Study: 36177365

Group type: EXPERIMENTAL
Intervention: Oxybuprocaine hydrochloride gel as urethral lubricant
Number of subjects: 192

Group type: COMPARATOR
Intervention: Liquid paraffin
Number of subjects: 192
Study: 35998039

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (1,000 mg) and pterostilbene (200 mg) supplementation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32347815

Group type: EXPERIMENTAL
Intervention: MILK intervention (n=126)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group receiving general perinatal SMS text messaging (Text4Baby; n=124)
Number of subjects: 250
Study: 35222888

Group type: EXPERIMENTAL
Intervention: Psychological care plus Chinese herbal decoction treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Psychotherapy
Number of subjects: 80
Study: 33683334

Group type: EXPERIMENTAL
Intervention: Compassion Cultivation Training (CCT)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 161
Study: 32988938

Group type: EXPERIMENTAL
Intervention: Public Health (PH) advertisements
Number of subjects: 2923

Group type: COMPARATOR
Intervention: SAPRO advertisements
Number of subjects: 2923
Study: 33103316

Group type: EXPERIMENTAL
Intervention: ADSC-CM plus 2% niacinamide
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 25
Study: 32532258

Group type: EXPERIMENTAL
Intervention: Danirixin 5, 10, 25, 35 or 50 mg twice daily
Number of subjects: 614

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 614
Study: 34004123

Group type: EXPERIMENTAL
Intervention: Enhanced Pulmonary Rehabilitation (EPR)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Traditional Pulmonary Rehabilitation (PR)
Number of subjects: 207
Study: 32865377

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 3730

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3730
Study: 36273218

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU weekly for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (1000 mg olive oil weekly for 8 weeks)
Number of subjects: 50
Study: 32791888

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention at Norwegian Healthy Life Centres
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 118
Study: 35619238

Group type: EXPERIMENTAL
Intervention: Synchronized diaphragmatic stimulation (SDS)
Number of subjects: 15
Study: 32563179

Group type: EXPERIMENTAL
Intervention: iPlayClean anti-doping education programme (face-to-face group presentation)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: iPlayClean anti-doping education programme (online)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: iPlayClean anti-doping education programme (face-to-face presentation with online access)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: iPlayClean anti-doping education programme (all modes)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: iPlayClean anti-doping education programme (face-to-face presentation)
Number of subjects: 1081

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1081
Study: 35565880

Group type: EXPERIMENTAL
Intervention: 30 g of whey protein (WP30)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 70 g of whey protein (WP70)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Non-caloric control (2 kcal)
Number of subjects: 8
Study: 34593169

Group type: EXPERIMENTAL
Intervention: Direct mail campaign using behavioral economics insights
Number of subjects: 12000

Group type: EXPERIMENTAL
Intervention: Messages used in the intervention
Number of subjects: 12000
Study: 35470320

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (TCS) with insonation angle >35 degrees
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Transcranial ultrasound (TCS) with insonation angle ≤15 degrees
Number of subjects: 100000
Study: 32910352

Group type: EXPERIMENTAL
Intervention: Psychologically empowered with safer sex intentions (profile 1)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Psychologically disempowered with safer sex intentions (profile 2)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Psychologically disempowered without safer sex intentions (profile 3)
Number of subjects: 275
Study: 34980223

Group type: EXPERIMENTAL
Intervention: FIL200+MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FIL100+MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FIL200
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ADA
Number of subjects: 0

Group type: COMPARATOR
Intervention: PBO+MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FIL200+csDMARD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FIL100+csDMARD
Number of subjects: 0

Group type: COMPARATOR
Intervention: PBO+csDMARD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FIL200+MTX, FIL100+MTX, FIL200, FIL100, ADA
Number of subjects: 0
Study: 34762377

Group type: EXPERIMENTAL
Intervention: ZHU Lian inhibition type Ⅰ acupuncture
Number of subjects: 82

Group type: COMPARATOR
Intervention: danshentong capsules (1 g, 3 times per day) and 0.1% adapalene gel smear (once every night) for 4 weeks
Number of subjects: 82
Study: 34196450

Group type: EXPERIMENTAL
Intervention: PBS programmes
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 240
Study: 32544970

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate in combination with prednisone/prednisolone (abiraterone/P)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study: 34854095

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg b.d.
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg b.d.
Number of subjects: 944

Group type: EXPERIMENTAL
Intervention: Tofacitinib (both dosages combined)
Number of subjects: 944
Study: 32000070

Group type: EXPERIMENTAL
Intervention: QL block (0.375% ropivacaine 20 ml bilaterally)
Number of subjects: 80

Group type: COMPARATOR
Intervention: TAP block (0.375% ropivacaine 20 ml bilaterally)
Number of subjects: 80
Study: 35549730

Group type: EXPERIMENTAL
Intervention: SGLT2 inhibitors
Number of subjects: 103247

Group type: COMPARATOR
Intervention: Non-SGLT2 inhibitors
Number of subjects: 103247
Study: 32220129

Group type: COMPARATOR
Intervention: BVM-only
Number of subjects: 3004

Group type: COMPARATOR
Intervention: BVM-rescue
Number of subjects: 3004
Study: 34998391

Group type: EXPERIMENTAL
Intervention: Chloroquine 150 mg (new coated tablet)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Primaquine 15 mg (new formulation)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Primaquine 5 mg (new formulation)
Number of subjects: 111
Study: 32162278

Group type: EXPERIMENTAL
Intervention: Oral appliance therapy (OAT) with a standardized stepwise titration protocol, starting at 60% of the maximum mandibular protrusion position.
Number of subjects: 36
Study: 36103970

Group type: EXPERIMENTAL
Intervention: 20° angle in reverse Trendelenburg (RT) position
Number of subjects: 91

Group type: COMPARATOR
Intervention: 0° supine position
Number of subjects: 91
Study: 32205221

Group type: EXPERIMENTAL
Intervention: RPC4046 (360 mg/wk)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo followed by RPC4046 (360 mg/wk)
Number of subjects: 66
Study: 35238873

Group type: EXPERIMENTAL
Intervention: HD201
Number of subjects: 502

Group type: COMPARATOR
Intervention: Referent trastuzumab
Number of subjects: 502
Study: 33837566

Group type: EXPERIMENTAL
Intervention: Family planning services (FPs) and sexual and reproductive health (SRH)
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Intrauterine devices (IUD)
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Tubal ligation
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Vasectomy
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Contraceptive failure
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Effective contraceptive usage after failure (TL and vasectomy)
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Naïve contraceptive users
Number of subjects: 17555

Group type: EXPERIMENTAL
Intervention: Demographic factors, awareness on FPs/SRH, discussing and making joint decision, and gender discrepancies
Number of subjects: 17555
Study: 36064594

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise group (MIAEG), 30-40 min/session, 3 days/week for 12 weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise group (MIAEG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG), no changes in exercise habits
Number of subjects: 60